NRG TRANSSEPTAL NEEDLE NRG-E-HF-71-C1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2019-04-29 for NRG TRANSSEPTAL NEEDLE NRG-E-HF-71-C1 manufactured by Baylis Medical Company Inc..

Event Text Entries

[143537884] Review of the device history record for the lot in question confirmed that all parts met manufacturing requirements prior to release. There is no evidence to suggest that the baylis medical device caused or contributed to the reported incident. However, as the baylis medical device was reported to be among the devices used in the procedure, baylis medical has decided to submit this report. There is no suspected device failure. The reported patient complication is an inherent risk in this type of procedure.
Patient Sequence No: 1, Text Type: N, H10


[143537885] The nrg transseptal needle (rf needle) was used for transseptal puncture in an ablation procedure. After inserting the rf needle into the patient's right atrium via a swartz sl1 sheath, the physician had difficulty in positioning the needle tip to the atrial septum (the patient had hypertrophic cardiomyopathy). As the location of the atrial septum could not be confirmed on echocardiography, right atrial angiography was used. After transseptal puncture was achieved as a result of multiple rf energy deliveries, the rf needle was advanced and replaced with a guidewire. Then, it was observed that the patient's blood pressure had decreased and it was suspected that the aorta had been inadvertently damaged. Cardiac drainage was performed but blood was not drained. The hospital staff prepared for percutaneous cardiopulmonary support (pcps). However, the blood pressure and bleeding both became stable without the need for pcps. The procedure was aborted. There is no evidence to suggest that the baylis medical device caused or contributed to the reported incident. However, as the baylis medical device was reported to be among the devices used in the procedure, baylis medical has decided to submit this report.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9710452-2019-00010
MDR Report Key8562936
Report SourceDISTRIBUTOR
Date Received2019-04-29
Date of Report2019-04-29
Date of Event2019-04-02
Date Mfgr Received2019-04-05
Date Added to Maude2019-04-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDR. MEGHAL KHAKHAR
Manufacturer Street2775 MATHESON BLVD. EAST
Manufacturer CityMISSISSAUGA, ONTARIO L4W 4P7
Manufacturer CountryCA
Manufacturer PostalL4W 4P7
Manufacturer G1BAYLIS MEDICAL COMPANY INC.
Manufacturer Street2775 MATHESON BLVD. EAST
Manufacturer CityMISSISSAUGA, ONTARIO L4W 4P7
Manufacturer CountryCA
Manufacturer Postal CodeL4W 4P7
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNRG TRANSSEPTAL NEEDLE
Generic NameRF TRANSSEPTAL NEEDLE
Product CodeDXF
Date Received2019-04-29
Model NumberNRG-E-HF-71-C1
Lot NumberNGFH060718
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBAYLIS MEDICAL COMPANY INC.
Manufacturer Address5959 TRANS-CANADA HIGHWAY MONTREAL, QUEBEC H4T 1A1 CA H4T 1A1


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-04-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.